Skip to main content
. 2023 Nov 29;11(12):3175. doi: 10.3390/biomedicines11123175

Figure 1.

Figure 1

Framework for automated prognosis marker assessment in breast cancer. (A–C) The BLEACH&STAIN multiplex fluorescence immunohistochemistry technology facilitates high throughput staining of 11 biomarkers on 1404 invasive breast cancers of no special type (NST). (D–F) A deep learning-based framework for automated breast cancer detection, comprising 16 deep learning systems, was used to enable automated prognosis markers assessment (schematic illustrations of the neural networks are shown in (D)).